BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27350054)

  • 21. Scientific basis and regulatory aspects for the toxicology of plant protection products in the European Union.
    Anadón A; Martínez-Larrañaga MR; Martínez MA
    Vet Hum Toxicol; 2001 Oct; 43(5):297-301. PubMed ID: 11577939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Science-based regulation of endocrine disrupting chemicals in Europe: which approach?
    Bourguignon JP; Slama R; Bergman Å; Demeneix B; Ivell R; Kortenkamp A; Panzica G; Trasande L; Zoeller RT
    Lancet Diabetes Endocrinol; 2016 Aug; 4(8):643-646. PubMed ID: 27312524
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk assessment of 'endocrine substances': guidance on identifying endocrine disruptors.
    Lewis RW
    Toxicol Lett; 2013 Dec; 223(3):287-90. PubMed ID: 24036001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Priority setting in the REACH system.
    Hansson SO; Rudén C
    Toxicol Sci; 2006 Apr; 90(2):304-8. PubMed ID: 16340010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial.
    Dietrich DR; von Aulock S; Marquardt H; Blaauboer B; Dekant W; Hengstler J; Collier A; Gori GB; Pelkonen O; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes AW; Gooderham N; Harvey A
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):317-20. PubMed ID: 23850959
    [No Abstract]   [Full Text] [Related]  

  • 26. Endocrine Disruption: Current approaches for regulatory testing and assessment of plant protection products are fit for purpose.
    Day P; Green RM; Gross M; Weltje L; Wheeler JR
    Toxicol Lett; 2018 Oct; 296():10-22. PubMed ID: 30006252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dekant W; Kehrer JP
    Toxicol Lett; 2013 Nov; 223(2):A1-4. PubMed ID: 23916789
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk assessment of endocrine disrupting chemicals--introduction to this special issue.
    van Ravenzwaay B; Dekant W; Vrijhof H
    Toxicol Lett; 2013 Dec; 223(3):269-70. PubMed ID: 24140152
    [No Abstract]   [Full Text] [Related]  

  • 29. Organic food: panacea for health?
    The Lancet
    Lancet; 2017 Feb; 389(10070):672. PubMed ID: 28229863
    [No Abstract]   [Full Text] [Related]  

  • 30. EU wrangles internally over safety of donated tissues and cells.
    Vermij P
    Nat Biotechnol; 2003 Dec; 21(12):1420. PubMed ID: 14647315
    [No Abstract]   [Full Text] [Related]  

  • 31. Science and regulation. New science for chemicals policy.
    Schwarzman MR; Wilson MP
    Science; 2009 Nov; 326(5956):1065-6. PubMed ID: 19965413
    [No Abstract]   [Full Text] [Related]  

  • 32. Endocrine Disruptors and Child Health: Food Contaminant Monitoring in the European Union.
    Bali D; Vural M; Pop TL; Carrasco-Sanz A; Giardino I; Pastore M; Pettoello-Mantovani M
    J Pediatr; 2023 Sep; 260():113520. PubMed ID: 37244574
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessment of three approaches for regulatory decision making on pesticides with endocrine disrupting properties.
    Marx-Stoelting P; Niemann L; Ritz V; Ulbrich B; Gall A; Hirsch-Ernst KI; Pfeil R; Solecki R
    Regul Toxicol Pharmacol; 2014 Dec; 70(3):590-604. PubMed ID: 25239592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modern regulatory impact analysis: the experience of the European Union.
    Ballantine B; Devonald B
    Regul Toxicol Pharmacol; 2006 Feb; 44(1):57-68. PubMed ID: 16307835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing and managing risks arising from exposure to endocrine-active chemicals.
    Phillips KP; Foster WG; Leiss W; Sahni V; Karyakina N; Turner MC; Kacew S; Krewski D
    J Toxicol Environ Health B Crit Rev; 2008 Mar; 11(3-4):351-72. PubMed ID: 18368561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of global regulatory toxicology requirements for vaccines and adjuvants.
    Sun Y; Gruber M; Matsumoto M
    J Pharmacol Toxicol Methods; 2012 Mar; 65(2):49-57. PubMed ID: 22326278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Streamlined chemical tests rebuffed.
    Gilbert N
    Nature; 2010 Jan; 463(7278):142-3. PubMed ID: 20075888
    [No Abstract]   [Full Text] [Related]  

  • 38. Integrative Strategy of Testing Systems for Identification of Endocrine Disruptors Inducing Metabolic Disorders-An Introduction to the OBERON Project.
    Audouze K; Sarigiannis D; Alonso-Magdalena P; Brochot C; Casas M; Vrijheid M; Babin PJ; Karakitsios S; Coumoul X; Barouki R
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. European Union bans atrazine, while the United States negotiates continued use.
    Sass JB; Colangelo A
    Int J Occup Environ Health; 2006; 12(3):260-7. PubMed ID: 16967834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; von Aulock S; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Batta Gori G; Pelkonen O; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Wallace Hayes A; Gooderham N; Harvey A
    ALTEX; 2013; 30(3):381-5. PubMed ID: 23861084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.